3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Stomach Neoplasms
3
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Biliary Tract Neoplasms
1
Interventions
Oxaliplatin
4
Fluorouracil
4
Magnetic Resonance Spectroscopy
3
5,10-methylenetetrahydrofolic acid
3
Ocoxin
2
Leucovorin
2
Irinotecan
2
Cyclophosphamide
2
Bevacizumab
2
trifluridine tipiracil drug combination
1
sintilimab
1
pralsetinib
1
pembrolizumab
1
napabucasin
1
huachansu
1
guadecitabine
1
Ursodeoxycholic Acid
1
Surveys and Questionnaires
1
S-1 plus cisplatin
1
Pharmaceutical Preparations
1
Pemetrexed
1
Paclitaxel
1
Oviposition
1
Levoleucovorin
1
Infliximab
1
Imatinib Mesylate
1
Gemcitabine
1
Exercise Test
1
Drainage
1
Docetaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Gastrointestinal Diseases
×
S-1 plus cisplatin
×
Clear all
NCT02322593
2021-12-20
SOLAR
Taiho Pharmaceutical Co., Ltd.
Phase 3
Completed
711 enrolled
16 charts